Home ABRAXANE Phase III Study of Patients with Metastatic Pancreatic...
 

Keywords :   


ABRAXANE Phase III Study of Patients with Metastatic Pancreatic...

2013-10-17 14:14:39| Biotech - Topix.net

Celgene International Sarl, a wholly-owned subsidiary of Celgene Corporation , today announced the results of the MPACT phase III clinical trial of ABRAXANE in combination with gemcitabine were published online in the October 16th edition of the New England Journal of Medicine .

Tags: study iii phase patients

Category:Biotechnology and Pharmaceuticals

Latest from this category

All news

»
28.09Tropical Storm Joyce Public Advisory Number 5
28.09Summary for Tropical Storm Joyce (AT1/AL112024)
28.09Post-Tropical Cyclone Helene Public Advisory Number 21
28.09Tropical Storm Joyce Forecast Discussion Number 5
28.09Tropical Storm Joyce Wind Speed Probabilities Number 5
28.09Tropical Storm Joyce Forecast Advisory Number 5
28.09Hurricane Isaac Graphics
28.09Hurricane Isaac Forecast Discussion Number 11
More »